That clean pulse is its defining characteristic
Fisone, G., Borgkvist, A., & Usiello, A
10.3389/fendo.2018.00117 3 BachL
First, women following pregnancy particularly those with significant skin excess, stretch marks or diastasis recti that has not resolved with physiotherapy
Weight loss goals are now disease-driven, not cosmetic 5% minimum meaningful benefit 10% required for most metabolic conditions 15% often needed for OSA, HFpEF, MASH, and severe obesity Medication choice is guided by comorbidities GLP-1 receptor agonists and dual GIP/GLP-1 agents are prioritized in patients with: Prediabetes & type 2 diabetes ASCVD Heart failure with preserved EF Metabolic liver disease Obstructive sleep apnea Cardiovascular outcomes now matter Semaglutide 2.4 mg demonstrated a significant reduction in major cardiovascular events even in people without diabetes
These medications influence the brains reward pathways, reducing cravings not just for food but also for substances like alcohol